Remove Disease Remove Doctors Remove Treatment Remove Virus
article thumbnail

Simple test for flu could improve diagnosis and surveillance

Broad Institute

Simple test for flu could improve diagnosis and surveillance By Allessandra DiCorato June 18, 2024 Breadcrumb Home Simple test for flu could improve diagnosis and surveillance A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.

Virus 144
article thumbnail

How to advance AAV-based gene therapies

Drug Discovery World

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies. Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas.

Therapies 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Where is the Ignite Theater tech leading us?

Drug Discovery World

For the patient as well as for doctors, this means creating more time to make decisions, as the company believes: “Patients – and their quality of life – shouldn’t have to wait for a broken system to provide an answer six months too late.

article thumbnail

Can a heartburn drug help doctors treat COVID-19?

The Pharma Data

In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. The next challenge was to figure out why.

Doctors 52
article thumbnail

Researchers uncover genetic factors for severe Lassa fever

Broad Institute

Researchers uncover genetic factors for severe Lassa fever By Allessandra DiCorato February 8, 2024 Breadcrumb Home Researchers uncover genetic factors for severe Lassa fever New findings from an international collaboration pave the way for studies of highly infectious diseases in Africa such as Ebola. Chan School of Public Health.

article thumbnail

Women in STEM with Delphine Guyon-Gellin

Drug Target Review

Last summer, we published a first signal of efficacy in humans in the LANCET Infectious Diseases for our lead broad-spectrum influenza candidate, OVX836. She holds a Doctorate from the Ecole Vétérinaire de Maisons-Alfort and a Master’s degree in Marketing from the HEC Paris.

Vaccine 108
article thumbnail

Finding the North Star of therapeutic antibodies

Drug Discovery World

Nipocalimab, according to Abouzahr, is currently the only FcRn being studied in all three segments of autoantibody-driven disease. She says: “At Janssen, we’re fortunate that we’re building on a leadership that we’ve created over the last couple of decades of treating immune-mediated diseases.